Remission of severe cold agglutinin disease after Rituximab therapy. 2001

N Layios, and E Van Den Neste, and E Jost, and V Deneys, and J M Scheiff, and A Ferrant

UI MeSH Term Description Entries
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000744 Anemia, Hemolytic, Autoimmune Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS. Anemia, Hemolytic, Idiopathic Acquired,Autoimmune Haemolytic Anaemia,Autoimmune Hemolytic Anemia,Cold Agglutinin Disease,Hemolytic Anemia, Autoimmune,Acquired Autoimmune Hemolytic Anemia,Anemia, Hemolytic, Cold Antibody,Cold Antibody Disease,Cold Antibody Hemolytic Anemia,Idiopathic Autoimmune Hemolytic Anemia,Agglutinin Disease, Cold,Anaemia, Autoimmune Haemolytic,Anemia, Autoimmune Hemolytic,Autoimmune Haemolytic Anaemias,Autoimmune Hemolytic Anemias,Cold Agglutinin Diseases,Cold Antibody Diseases,Haemolytic Anaemia, Autoimmune
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D058846 Antibodies, Monoclonal, Murine-Derived Antibodies obtained from a single clone of cells grown in mice or rats. Murine-Derived Monoclonal Antibodies,Antibodies, Murine-Derived Monoclonal,Monoclonal Antibodies, Murine-Derived,Murine Derived Monoclonal Antibodies

Related Publications

N Layios, and E Van Den Neste, and E Jost, and V Deneys, and J M Scheiff, and A Ferrant
August 2003, La Revue de medecine interne,
N Layios, and E Van Den Neste, and E Jost, and V Deneys, and J M Scheiff, and A Ferrant
May 2021, The journal of allergy and clinical immunology. In practice,
N Layios, and E Van Den Neste, and E Jost, and V Deneys, and J M Scheiff, and A Ferrant
May 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
N Layios, and E Van Den Neste, and E Jost, and V Deneys, and J M Scheiff, and A Ferrant
May 1989, Deutsche medizinische Wochenschrift (1946),
N Layios, and E Van Den Neste, and E Jost, and V Deneys, and J M Scheiff, and A Ferrant
October 2020, Pediatrics international : official journal of the Japan Pediatric Society,
N Layios, and E Van Den Neste, and E Jost, and V Deneys, and J M Scheiff, and A Ferrant
October 2001, British journal of haematology,
N Layios, and E Van Den Neste, and E Jost, and V Deneys, and J M Scheiff, and A Ferrant
October 2012, International journal of hematology,
N Layios, and E Van Den Neste, and E Jost, and V Deneys, and J M Scheiff, and A Ferrant
August 1964, California medicine,
N Layios, and E Van Den Neste, and E Jost, and V Deneys, and J M Scheiff, and A Ferrant
August 2008, International journal of laboratory hematology,
N Layios, and E Van Den Neste, and E Jost, and V Deneys, and J M Scheiff, and A Ferrant
May 2006, Anales de medicina interna (Madrid, Spain : 1984),
Copied contents to your clipboard!